In silico design of novel quinazoline-based compounds as potential Mycobacterium tuberculosis PknB inhibitors through 2D and 3D-QSAR, molecular dynamics simulations combined with pharmacokinetic predictions. (2022)

First Author: Hanwarinroj C

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/j.jmgm.2022.108231

PubMed Identifier: 35667143

Publication URI: http://europepmc.org/abstract/MED/35667143

Type: Journal Article/Review

Volume: 115

Parent Publication: Journal of molecular graphics & modelling

ISSN: 1093-3263